Cargando...
AAV gene therapy for cystic fibrosis: current barriers and recent developments
INTRODUCTION: Since the CF gene was discovered in 1989, researchers have worked to develop a gene therapy. One of the most promising and enduring vectors is AAV, which has been shown to be safe. In particular, several clinical trials have been conducted with AAV serotype 2. All of them detected vira...
Gardado en:
| Publicado en: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5858933/ https://ncbi.nlm.nih.gov/pubmed/28657358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2017.1347630 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|